Imagine a world where anyone who needs a bone marrow transplant can get one — on demand. No more desperate donor searches or deadly delays. Kevin Caldwell, Co-Founder & CEO, Ossium Health.
Bone marrow transplants have always depended on finding the right donor at the right time. But what if bone marrow could be stored, shipped, and used on demand—just like a drug? That’s exactly what Ossium Health is now showing in human clinical data.
Kevin Caldwell is the Co-Founder, CEO, and President of Ossium Health (https://ossiumhealth.com/), a clinical-stage bioengineering company pioneering off-the-shelf, cryopreserved bone marrow therapies derived from deceased organ donors.
Under Kevin’s leadership, Ossium has developed a novel platform designed to solve one of the most persistent challenges in transplantation medicine: timely access to compatible bone marrow for patients with life-threatening hematologic malignancies such as Acute Myeloid Leukemia. The company’s approach enables on-demand delivery of viable marrow cells, bypassing the logistical and biological constraints of traditional donor matching and scheduling.
Since its founding, Kevin has scaled Ossium from an early-stage startup into a clinical-stage company with a robust network of over 50 strategic partnerships across supply, clinical development, and commercial channels. He has led multiple financings and secured a landmark contract with the Biomedical Advanced Research and Development Authority, validating Ossium’s relevance to national health preparedness and biomanufacturing resilience.
If you want to know more about the @HP ZBook Ultra G1a Powered by an @AMD Ryzen™ AI MAX Pro 300 Series Processor, click the link below. https://www.hp.com/us-en/workstations… Projects (Chrysalis, WFP, Sistema Stellare Proximum) https://www.projecthyperion.org/ My Research Booklet https://nollimedia.com/hyperion_bookl… My Merch: https://damilee.com/collections/gear Become a channel producer: https://ko-fi.com/damilee/tiers Music and Stock footage by Artlist (2 additional months free on any annual plan if you use my link): https://bit.ly/3GxTfQ6 Join the Discord Server: / discord JOIN MY NEWSLETTER: https://www.damilee.com/pages/newsletter DESK + ACCESSORIES: Ergonofis Sway Desk https://bit.ly/3W3sHNi Ergonofis Shift Desk https://bit.ly/3YtHzq4 Film Equipment Black Magic PCC 6K PRO: https://amzn.to/3YiAAz6 Insta360 RS ONE http://bit.ly/3HjifLy Sony FX30 https://amzn.to/3gDAqCw Laowa Probe Lens : https://amzn.to/3HOWvIK Sirui Night Walker https://amzn.to/40mVIbZ IPad Pro 13 Inches M4 https://amzn.to/40hH1a1 Hollyland MARS https://amzn.to/41GJKYt Hollyland Lark M2 https://amzn.to/3Xf9QiA Aputure Amaran RGB stick https://amzn.to/3A8gh18 RONIN RS-4 https://amzn.to/4f1o6F0 Small Rig COB lighs https://amzn.to/4fqkPip Edited With Davinci Resolve https://bit.ly/4hgUEMC Book Recommendations: https://damilee.com/pages/recommended… INSTAGRAM — / damileearch TWITTER — / damileearch LINKEDIN — / damilee TIKTOK — / damileearch WHO AM I: I’m Dami, a licensed Architect living in Vancouver, BC. I make videos about architecture, career, and creativity. WEBSITES https://www.damilee.comhttps://nollimedia.com/ Filmmaking by Raffaele di Nicola Raffaele di Nicola IG @nollistudio Special Thanks @TheNetworkHub Vancouver https://thenetworkhub.ca/ GET IN TOUCH: If you’d like to talk, I’d love to hear from you! Commenting on a video or tweeting @damileearch will be the quickest way to get a response from me, but if your question is very long, feel free to email me at [email protected]. I try my best to respond to the emails, but unfortunately, there just aren’t enough hours in the day! A NOLLISTUDIO/NOLLIMEDIA Production http://www.nollistudio.com@HPInc@AMD #InterstellarTravel #GenerationShip #SpaceArchitecture #SpaceColonization #FutureOfHumanity #SpaceExploration #Megastructures #Architecture #Engineering #SciFi #SpaceDesign #DeepSpace #HumanSpaceflight #SpaceHabitat #AsteroidMining #Interstellar #SpaceSettlement #FutureEngineering #ClosedLoopSystems #SpaceTechnology #ad #AMD #Ryzen #RyzenAI What would it actually take to leave Earth — not for a weekend on the Moon, but forever? This video tests three real generation-ship proposals against five brutal constraints: gravity, radiation, closed-loop life support, cultural continuity across 400 years, and the selection problem — choosing who gets to go. We break down Chrysalis (a 58 km modular ship that sheds stages like a rocket), Proximum (a civilization carved inside an asteroid), and WFP (a self-assembling micro-city based on MIT research). Along the way we confront governance without a homeworld, genetic bottlenecks, generational memory loss, and why shared rituals might matter more than engine specs. The answer isn’t one ship — it’s three radically different philosophies of what it means to be human in deep space.
LigandForge generates 150,000 peptide drug candidates in 3 minutes — a million times faster than existing methods, unlocking a tsunami of possible treatments.
A man with no medical background used ChatGPT, AlphaFold, and Grok to design a custom mRNA cancer vaccine for his dying dog — and her biggest tumor shrank 75%.
Meanwhile, scientists discovered a single protein that literally spreads aging through your bloodstream. These stories are each incredible on their own. But the big story is the implications for curing aging.
In this deep dive, I break down how these three breakthroughs fit together, what peptides and mRNA vaccines actually are (and how they’re different), and why this moment might be the most important inflection point in the history of drug design.
The age of custom AI cures isn’t coming. It’s here.
Nicholas F. Kuhn, Matthew F. Krummel et al. demonstrate how local gene editing of cancer-associated fibroblasts alters their cell state and, subsequently, the cellular tumor microenvironment.
CAFs are prominent members of the TME. Kuhn et al. demonstrate how local gene editing of CAFs alters their cell state and, subsequently, the cellular TME.
A fascination with fish gills has led researchers at Cornell to develop a bio-inspired approach to mixing heat and molecules in fluids—findings that could inform future biomedical devices, heat exchangers and soft robotics.
Moving heat and mass efficiently through flowing liquids is central to technologies ranging from dialysis machines to industrial cooling systems, yet many of those technologies rely on rigid components to get the job done.
Looking for an alternative, Yicong Fu, a mechanical engineering doctoral student, turned to fish gills—soft, porous tissue that constantly stirs water to keep gases and ions flowing. Working with Sunghwan “Sunny” Jung, professor of biological and environmental engineering in the College of Agriculture and Life Sciences, Fu designed a gill-like thermal dispenser that is providing new insights into fluid-structure interactions.
Penn Engineers have redesigned a key component of lipid nanoparticles (LNPs), the delivery vehicles behind mRNA vaccines, to steer the particles toward lymph nodes while reducing off-target delivery to the liver. The advance could make mRNA vaccines more efficient, potentially achieving strong immune protection at lower doses.
“The more particles that reach the lymph nodes, the fewer particles each dose needs,” says Michael J. Mitchell, Associate Professor in Bioengineering (BE) and senior author of a new study in Journal of the American Chemical Society that describes how the researchers modified the ionizable lipid, a key LNP ingredient that helps mRNA enter cells.
In animal models, the new “aroLNPs,” whose name refers to the addition of a chemical structure called an “aromatic ring” to the ionizable lipid, delivered at least 10-fold less mRNA to the liver compared to the LNP formulation in the Moderna COVID-19 vaccine, while maintaining similar levels of lymph-node delivery.
A new study has for the first time elucidated the gut-liver immune regulatory axis jointly maintained by intestinal commensal bacteria and the intestinal endocrine system, and uncovered the fundamental mechanism underlying the body’s nonspecific clearance of drug delivery carriers. It provides a universal solution to the core problem plaguing the delivery field for decades, significantly improves the delivery efficiency and therapeutic effect of tumor-targeted therapy, mRNA therapy, gene editing and other treatments, and blazes a new trail for the clinical translation of biomedical delivery technologies.
The research team led by Professors Wang Yucai, Zhu Shu and Jiang Wei from the University of Science and Technology of China (USTC) published their research paper titled “Commensal-driven serotonin production modulates in vivo delivery of synthetic and viral vectors” in Science on March 19.
The trajectory of base editing has been remarkable, progressing from the laboratory to patient care, treating debilitating or terminal illnesses, in less than a decade. A type of gene editing that makes chemical changes to our DNA, base editing was developed by Alexis Komor, associate professor in the Department of Biochemistry and Molecular Biophysics at the University of California San Diego.
For all of base editing’s success, it is still a relatively new technology, and researchers like Komor are working to improve its efficiency, while lowering the incidence of unwanted edits. One type of unwanted edit is called a bystander edit. This occurs when a base editor not only edits the desired nucleobase, but also edits surrounding bases as well. Komor’s lab has developed a way to minimize bystander edits. This work appears in Nature Biotechnology.
BMC Biology is calling for submissions to our Collection on Regeneration: wound healing, reprogramming, and tissue engineering. This Collection aims to bring together cutting-edge research exploring the cellular and molecular mechanisms of wound healing and repair, cellular reprogramming as a means of achieving tissue regeneration in vivo or in vitro, as well as advances in tissue engineering, aiming at replacing damaged cells and organs via transplantation.
We welcome studies on:
- Investigating processes involved in wound healing, including inflammation, re-epithelialization, cell fusion, fibroblast activation, scar formation, angiogenesis, and extracellular matrix (ECM) remodeling.
Dr. Nicolas Rouleau is a neuroscientist, bioengineer, and Assistant Professor of Health Sciences at Wilfrid Laurier University. He wrote the award-winning essay, ‘An Immortal Stream of Consciousness: The scientific evidence for the survival of consciousness after permanent bodily death,’ in which he argues that the transmissive theory of consciousness may actually be more consistent with emerging scientific insights than the dominant assumption that the brain generates consciousness.
In this conversation with Hans Busstra, Rouleau shares the main arguments from his essay, which touch upon his collaboration with Dr. Michael Persinger, the inventor of the ‘God Helmet,’ and his work with Michael Levin on ‘mind blindness’—the idea that science may be searching for mind in too restricted a place by focusing almost exclusively on neurons.
Further reading and scientific references discussed in this video:
Rouleau’s BICS Essay: ‘An Immortal Stream of Consciousness: The scientific evidence for the survival of consciousness after permanent bodily death.’ https://www.bigelowinstitute.org/inde…
Rouleau, N., Levin, M., et al. (2025) (Preprint; forthcoming in Philosophical Transactions of the Royal Society). Brains and Where Else? Mapping Theories of Consciousness to Unconventional Embodiments. https://tinyurl.com/439rrn8z.
